Related Experiment Video
Updated: Dec 28, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Prevalence and determinants of elevated D-dimer in patients with hypertrophic cardiomyopathy
Chengzhi Yang1, Changlin Zhang2, Jiansong Yuan2
1Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Insights
Patients with hypertrophic cardiomyopathy (HCM) may have elevated D-dimer levels. Age, sex, and statin therapy are key factors influencing these D-dimer levels in HCM patients.
Area of Science:
- Cardiology
- Biomarkers
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Understanding associated biomarkers like D-dimer is crucial for patient management.
Purpose of the Study:
- To investigate D-dimer levels in patients diagnosed with hypertrophic cardiomyopathy.
- To identify factors associated with elevated D-dimer in this population.
Main Methods:
- Recruited 346 patients with hypertrophic cardiomyopathy (HCM).
- Measured plasma D-dimer levels using standard laboratory methods.
- Assessed cardiac function parameters including left ventricular mass, stroke volume, cardiac output, and cardiac index via cardiovascular magnetic resonance imaging.
Main Results:
- 10.4% of HCM patients exhibited elevated D-dimer levels.
- Independent predictors for elevated D-dimer included older age, female sex, and statin therapy.
- Atrial fibrillation and diastolic blood pressure also influenced D-dimer levels.
Conclusions:
- Plasma D-dimer levels may be elevated in patients with hypertrophic cardiomyopathy compared to healthy individuals.
- D-dimer levels in HCM are multifactorial, influenced by demographic and clinical factors.
Abstract:
Aim: To evaluate D-dimer levels in patients with hypertrophic cardiomyopathy (HCM). Patients & methods: A total of 346 patients with HCM were recruited. Plasma D-dimer was determined by clinical laboratory of our hospital. Left ventricular mass, stroke volume, cardiac output and cardiac index were assessed with cardiovascular magnetic resonance. Results: A total of 36 (10.4%) patients had elevated D-dimer levels. Age, female patients and statin therapy were independently associated with increasing D-dimer levels, and predictors of elevated D-dimer. Conclusion: Patients with HCM may have higher plasma D-dimer levels than subjects without HCM. D-dimer levels in patients with HCM are influenced by age, sex, atrial fibrillation, statin therapy and diastolic blood pressure.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease I: Introduction
Cardiomyopathy V: Interprofessional Care

